Straits Times Index
2,949.04-24.50(-0.82%)Nikkei
28,966.01-1,202.26(-3.99%)Hang Seng
28,980.21-1,093.96(-3.64%)
Bionano Genomics, Inc. (BNGO)
| Previous close | 10.02 |
| Open | 10.09 |
| Bid | 9.97 x 800 |
| Ask | 9.97 x 2200 |
| Day's range | 9.38 - 10.71 |
| 52-week range | 0.25 - 15.69 |
| Volume | 14,418,204 |
| Avg. volume | 87,600,381 |
| Market cap | 2.695B |
| Beta (5Y monthly) | 2.37 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.52 |
| Earnings date | 12 Nov 2020 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 10.94 |
- Motley Fool
Is It Too Late to Buy Bionano Genomics Stock?
Bionano Genomics (NASDAQ: BNGO) has certainly created a buzz in 2021. It's one of the top 100 most-popular stocks on Robinhood. Bionano's shares have skyrocketed more than 340% so far this year.
- Motley Fool
Is BioNano Genomics Stock a Buy?
If you don't have an answer to this (large, open-ended, highly technical) question, don't worry: BioNano Genomics (NASDAQ: BNGO) might. As its name implies, the company makes laboratory equipment that helps researchers and clinicians answer a narrow subset of those thorny genomics questions. BioNano's Saphyr genome mapping device detects large structural variations and aberrations in chromosomes, which is something that standard gene sequencers can't do.
- Motley Fool
Why Bionano Genomics Stock Surged Today
What happened Shares of Bionano Genomics (NASDAQ: BNGO) hit a record high on Friday. By the close of trading, the genome analysis company's stock price was up 17%. So what On Thursday, Bionano Genomics released a study showing that its Saphyr optical genome mapping (OGM) system could be used to analyze a wide variety of solid tumors in cancer research.
